# Analysis of an Unknown Oxford Nanopore Bacterial Isolate

## 1. Executive Summary

I analyzed an unknown bacterial isolate using Oxford Nanopore (ONT) sequencing data. Starting from the raw reads, I performed quality control, genome assembly, species identification, antimicrobial resistance analysis, plasmid analysis, and virulence analysis.

I identified the isolate as **Klebsiella pneumoniae ST258**. I detected several antimicrobial resistance genes, including **blaKPC-3**, which provides resistance to carbapenem antibiotics. This indicates that the isolate is multidrug-resistant (MDR).

Plasmid analysis showed that **blaKPC-3** and an **IncI2 plasmid replicon** are located on the same contig. This strongly suggests that the resistance gene is plasmid-associated and may spread to other bacteria. However, because the genome assembly is a draft assembly, this cannot be confirmed with complete certainty.

I did not detect major hypervirulence genes, suggesting that this isolate is a classical multidrug-resistant *Klebsiella pneumoniae* rather than a hypervirulent strain.

Overall, the analysis shows that the isolate is **Klebsiella pneumoniae ST258** carrying a plasmid-associated **blaKPC-3** resistance gene. These results should be considered together with routine laboratory susceptibility testing before making treatment decisions.

---

## 2. Objectives

The objective of this analysis was to identify an unknown bacterial isolate using only the raw Oxford Nanopore (ONT) sequencing reads. I also aimed to determine its antimicrobial resistance profile, investigate whether the resistance genes were located on the chromosome or on a plasmid, and identify any important virulence factors.

To achieve this, I performed a complete bioinformatics workflow, from quality assessment and genome assembly to species identification, sequence typing, antimicrobial resistance analysis, plasmid analysis, and virulence analysis. I recorded all tools, commands, and database versions to ensure that the analysis can be reproduced.

---

## 3. Input Data

The analysis started with a single Oxford Nanopore Technologies (ONT) sequencing file:

- **File:** `unknown_isolate.fastq.gz`
- **Data type:** Raw ONT sequencing reads

No additional information about the organism, sequencing run, or sample was provided. Therefore, I performed the complete analysis using only the raw sequencing reads.

---

## 4. Analysis Workflow

### 4.1 Quality Assessment

I first checked the quality of the raw Oxford Nanopore reads using **NanoPlot**, **NanoStat**, and **SeqKit**. This allowed me to examine the number of reads, read length, total bases, and overall data quality before starting the analysis.

### 4.2 Genome Assembly

After confirming that the sequencing data was suitable for analysis, I assembled the genome using **Flye**. I chose Flye because it is designed for long-read sequencing data produced by Oxford Nanopore Technologies.

### 4.3 Species Identification

After the assembly was completed, I identified the organism by comparing the assembled genome with reference sequences using **NCBI BLAST**. I also used **Kleborate** to confirm the species and obtain additional information about the isolate.

### 4.4 Sequence Typing (MLST)

I performed **MLST (Multi-Locus Sequence Typing)** analysis to identify the sequence type (ST) of the isolate. This helped determine the lineage of the bacterium.

### 4.5 Antimicrobial Resistance Analysis

To identify antimicrobial resistance genes, I analyzed the assembled genome using **AMRFinderPlus**. This allowed me to detect resistance genes and evaluate whether the isolate carried resistance to clinically important antibiotics.

### 4.6 Plasmid Analysis

I used **PlasmidFinder** to identify plasmid replicons in the assembled genome. After detecting the **blaKPC-3** resistance gene on **contig_17**, I analyzed this contig separately to determine whether the resistance gene was associated with a plasmid.

### 4.7 Virulence Analysis

Finally, I analyzed the assembled genome using **Kleborate** to identify important virulence genes. This helped determine whether the isolate belonged to a hypervirulent lineage or a classical multidrug-resistant lineage.

---

## 5. Results

### 5.1 Quality Assessment

| Metric | Result |
|---------|--------|
| Total reads | 260,294 |
| Total bases | 576,590,333 bp |
| Mean read length | 2,215 bp |
| Longest read | 210,485 bp |

Based on the quality assessment, I concluded that the sequencing data was suitable for downstream analysis.

---

### 5.2 Genome Assembly

| Metric | Result |
|---------|--------|
| Genome size | 5,866,562 bp |
| Number of contigs | 14 |
| Largest contig | 5,306,290 bp |
| N50 | 5,306,290 bp |
| Coverage | ~97× |

I obtained a draft genome assembly consisting of 14 contigs with approximately 97× coverage.

---

### 5.3 Species Identification

| Analysis | Result |
|----------|--------|
| Species | **Klebsiella pneumoniae** |
| Sequence Type (MLST) | **ST258** |

I identified the isolate as **Klebsiella pneumoniae ST258** based on the assembly and species identification analyses.

---

### 5.4 Antimicrobial Resistance Genes

| Gene | Associated resistance |
|------|-----------------------|
| blaKPC-3 | Carbapenems |
| blaSHV-12 | Extended-spectrum β-lactams (ESBL) |
| blaSHV-11 | β-lactams |
| blaTEM-1 | β-lactams |
| blaOXA-9 | β-lactams |
| aac genes | Aminoglycosides |
| aad genes | Aminoglycosides |
| aph genes | Aminoglycosides |
| sul1, sul3 | Sulfonamides |
| dfrA12 | Trimethoprim |
| fosA | Fosfomycin |
| catA1 | Chloramphenicol |
| mph(A) | Macrolides |
| oqxA, oqxB | Multidrug efflux pump |

I identified multiple antimicrobial resistance genes, including **blaKPC-3**, which is associated with resistance to carbapenem antibiotics. These findings indicate that the isolate is multidrug-resistant (MDR).

---

### 5.5 Plasmid Analysis

PlasmidFinder detected the following plasmid replicons:

- IncR
- IncFIB(K)
- IncFII(K)
- IncFII(Yp)
- IncI2

I found the **blaKPC-3** gene on **contig_17**. The same contig also contained an **IncI2 plasmid replicon** with **100% coverage** and **98.42% identity**, suggesting that the resistance gene is likely plasmid-associated.

---

### 5.6 Virulence Analysis

| Feature | Result |
|---------|--------|
| Species confirmation | Klebsiella pneumoniae |
| Sequence Type | ST258 |
| Virulence score | 0 |
| Capsule type | KL107 |
| O antigen | O13 |

I did not detect any major hypervirulence genes, including aerobactin, salmochelin, yersiniabactin, colibactin, rmpA, or rmpA2. These findings suggest that the isolate is a classical multidrug-resistant **Klebsiella pneumoniae** rather than a hypervirulent strain.

---

## 6. Interpretation

Based on my analysis, I identified the unknown isolate as **Klebsiella pneumoniae ST258**. This lineage is commonly associated with multidrug-resistant hospital infections.

The most important finding was the presence of the **blaKPC-3** gene. This gene is associated with resistance to carbapenem antibiotics, which are often used as one of the last treatment options for severe bacterial infections. I also detected several other resistance genes, indicating that the isolate is multidrug-resistant (MDR).

I found that the **blaKPC-3** gene and an **IncI2 plasmid replicon** were located on the same contig. This suggests that the resistance gene is likely plasmid-associated and may be transferred to other bacteria. However, because the genome assembly is still a draft assembly, I interpreted this finding with caution.

I did not detect any major hypervirulence genes. This suggests that the isolate is a classical multidrug-resistant *Klebsiella pneumoniae* rather than a hypervirulent strain.

Overall, I concluded that this isolate is an important clinical pathogen because it carries resistance to several antibiotic classes, including carbapenems. However, these genomic findings should be confirmed with routine antimicrobial susceptibility testing before making treatment decisions.

---

## 7. Limitations

I think this analysis has some limitations that should be considered.

- I obtained a **draft genome assembly**, not a complete closed genome.
- I found the **blaKPC-3** gene and an **IncI2 plasmid replicon** on the same contig. This strongly suggests that the resistance gene is likely plasmid-associated, but it does not prove that the gene is located on a complete plasmid.
- I predicted antimicrobial resistance using genomic data only. I think the actual resistance phenotype should be confirmed with routine antimicrobial susceptibility testing.
- I evaluated virulence using known virulence genes only. Therefore, I may not have detected unknown or uncharacterized virulence factors.

Despite these limitations, I believe that my results provide strong evidence for the identification of the organism and its antimicrobial resistance profile.

---

## 8. Conclusion

Using only the raw Oxford Nanopore sequencing reads, I identified the unknown isolate as **Klebsiella pneumoniae ST258**.

I detected multiple antimicrobial resistance genes, including **blaKPC-3**, which is associated with resistance to carbapenem antibiotics. I also found that this resistance gene and an **IncI2 plasmid replicon** were located on the same contig, suggesting that the gene is likely plasmid-associated.

I did not detect any major hypervirulence genes. Based on these findings, I concluded that the isolate is a classical multidrug-resistant *Klebsiella pneumoniae* rather than a hypervirulent strain.

Overall, I successfully identified the organism, characterized its antimicrobial resistance profile, and obtained additional information about plasmid-associated resistance and virulence. I believe that these findings can support further laboratory testing and clinical decision-making.

---

## 9. Note to Professor Kılıç

Dear Professor Kılıç,

I identified the unknown isolate as **Klebsiella pneumoniae ST258**. This bacterium carries several antibiotic resistance genes, including **blaKPC-3**, which is associated with resistance to carbapenem antibiotics. These antibiotics are often used when other treatments are not effective.

My analysis also suggests that this resistance gene may be carried on a plasmid. If confirmed, this means the resistance could potentially spread to other bacteria.

I did not detect major hypervirulence genes, which suggests that this isolate is not a hypervirulent strain.

I recommend confirming these genomic findings with routine antimicrobial susceptibility testing before making treatment decisions. If needed, additional laboratory tests can also be performed to confirm the location of the resistance gene.

Kind regards,

**Dudu Kabakçı**

---

## 10. Tools and Database Versions

| Tool / Database | Version | Purpose |
|-----------------|---------|---------|
| NanoPlot | v1.47.1 | Quality assessment |
| NanoStat | v1.6.0 | Read statistics |
| SeqKit | v2.13.0 | FASTA/FASTQ statistics and sequence extraction |
| Flye | v2.9.6-b1802 | Genome assembly |
| NCBI BLAST | Web version | Species confirmation |
| mlst | v2.35.0 | Sequence typing (MLST) |
| AMRFinderPlus | v4.2.7 | Antimicrobial resistance gene detection |
| AMRFinderPlus Database | 2026-05-15.1 | AMR reference database |
| PlasmidFinder | Web version | Plasmid replicon detection |
| PlasmidFinder Database | Latest database available during analysis | Plasmid reference database |
| Kleborate | v3.1.3 | Species confirmation, virulence analysis, and sequence typing |

**Note:** I used the NCBI BLAST web interface for species confirmation. All other analyses were performed locally using the command-line versions of the tools listed above.
---

## 11. References

1. Kolmogorov M, Yuan J, Lin Y, Pevzner PA. **Assembly of long, error-prone reads using repeat graphs.** *Nature Biotechnology.* 2019;37(5):540–546.

2. Camacho C, Coulouris G, Avagyan V, et al. **BLAST+: architecture and applications.** *BMC Bioinformatics.* 2009;10:421.

3. Seemann T. **mlst: Scan contig files against PubMLST typing schemes.** Available at: https://github.com/tseemann/mlst

4. Feldgarden M, Brover V, Gonzalez-Escalona N, et al. **AMRFinderPlus and the Reference Gene Catalog facilitate examination of the genomic links among antimicrobial resistance, stress response, and virulence.** *Scientific Reports.* 2021;11:12728.

5. Carattoli A, Zankari E, García-Fernández A, et al. **In Silico Detection and Typing of Plasmids using PlasmidFinder and Plasmid Multilocus Sequence Typing.** *Antimicrobial Agents and Chemotherapy.* 2014;58(7):3895–3903.

6. Lam MMC, Wick RR, Watts SC, et al. **A genomic surveillance framework and genotyping tool for Klebsiella pneumoniae and its related species complex.** *Nature Communications.* 2021;12:4188.

7. De Coster W, D'Hert S, Schultz DT, Cruts M, Van Broeckhoven C. **NanoPack: visualizing and processing long-read sequencing data.** *Bioinformatics.* 2018;34(15):2666–2669.

8. Shen W, Le S, Li Y, Hu F. **SeqKit: A Cross-Platform and Ultrafast Toolkit for FASTA/Q File Manipulation.** *PLOS ONE.* 2016;11(10):e0163962.